Patents by Inventor JULIAN BERGER

JULIAN BERGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12280115
    Abstract: Cytokine-bisphosphonate conjugates and methods of use thereof in muscle functions.
    Type: Grant
    Filed: April 9, 2024
    Date of Patent: April 22, 2025
    Assignees: The Trustees of Columbia University in the City of New York, William Marsh Rice University
    Inventors: Gerard Karsenty, Julian Berger, Han Xiao
  • Patent number: 12215132
    Abstract: Exemplary methods, compositions and uses thereof can be provided for preventing, reducing and/or treating loss of muscle function. In particular, e.g., it is possible to administer to a subject a pharmaceutical composition comprising a therapeutically effective amount of an agent that enhances Interleukin-6 (IL) release during exercise, and optionally a pharmaceutically acceptable carrier or excipient.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: February 4, 2025
    Assignees: The Trustees of Columbia University in the City of New York, William Marsh Rice University
    Inventors: Gerard Karsenty, Julian Berger, Han Xiao
  • Publication number: 20240269294
    Abstract: Methods for treating muscle loss and exercise capacity pathologies by controlling osteocalcin release, and compositions therefor, are provided.
    Type: Application
    Filed: April 9, 2024
    Publication date: August 15, 2024
    Inventors: Gerard Karsenty, Julian Berger, Han Xiao
  • Publication number: 20220106376
    Abstract: Exemplary methods, compositions and uses thereof can be provided for preventing, reducing and/or treating loss of muscle function. In particular, e.g., it is possible to administer to a subject a pharmaceutical composition comprising a therapeutically effective amount of an agent that enhances Interleukin-6 (IL) release during exercise, and optionally a pharmaceutically acceptable carrier or excipient.
    Type: Application
    Filed: October 18, 2021
    Publication date: April 7, 2022
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: GERARD KARSENTY, JULIAN BERGER
  • Publication number: 20220106372
    Abstract: Exemplary methods, compositions and uses thereof can be provided for preventing, reducing and/or treating loss of muscle function. In particular, e.g., it is possible to administer to a subject a pharmaceutical composition comprising a therapeutically effective amount of an agent that enhances Interleukin-6 (IL) release during exercise, and optionally a pharmaceutically acceptable carrier or excipient.
    Type: Application
    Filed: October 18, 2021
    Publication date: April 7, 2022
    Inventors: GERARD KARSENTY, JULIAN BERGER